HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)

Lohaus F, Linge A, Tinhofer I, Budach V, Gkika E, Stuschke M, Balermpas P, Roedel C, Avlar M, Grosu AL, Abdollahi A, Debus J, Bayer C, Belka C, Pigorsch S, Combs SE, Moennich D, Zips D, Von Neubeck C, Baretton GB, Loeck S, Thames HD, Krause M, Baumann M (2014)

Publication Type: Journal article

Publication year: 2014

Journal

Radiotherapy and Oncology Elsevier

Book Volume: 113

Pages Range: 317-323

Journal Issue: 3

DOI: 10.1016/j.radonc.2014.11.011

Abstract

Objective To investigate the impact of HPV status in patients with locally advanced head and neck squamous cell carcinoma (HNSCC), who received surgery and cisplatin-based postoperative radiochemotherapy.

Involved external institutions

Deutsches Krebsforschungszentrum (DKFZ) DE Germany (DE) Goethe-Universität Frankfurt am Main DE Germany (DE) Technische Universität Dresden DE Germany (DE) University of Texas MD Anderson Cancer Center US United States (USA) (US)

How to cite

APA:

Lohaus, F., Linge, A., Tinhofer, I., Budach, V., Gkika, E., Stuschke, M.,... Baumann, M. (2014). HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiotherapy and Oncology, 113(3), 317-323. https://doi.org/10.1016/j.radonc.2014.11.011

MLA:

Lohaus, Fabian, et al. "HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)." Radiotherapy and Oncology 113.3 (2014): 317-323.

BibTeX: Download